Global Biosynthesis of Cannabinoids Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Latest Trends
Publisher : MRA | Format : PDF
Global Biosynthesis of Cannabinoids Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
Cannabinoids are found in the cannabis plant, they can be produced in biosynthesis way. While biosynthesis has not yet proven itself as a scalable technology, it has the potential to radically alter the way cannabinoids are manufactured in the near future.These compounds are the exact same as what cannabis expresses.
Biosynthesis of Cannabinoids report published by MRA Research reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2023. Global Biosynthesis of Cannabinoids market is projected to reach US$ million in 2033, increasing from US$ million in 2023, with the CAGR of % during the period of 2023 to 2033. Demand from Food Industry and Medical Industry are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Biosynthesis of Cannabinoids industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033.
Globally, Biosynthesis of Cannabinoids key companies include Anandia Laboratories, Gingko Bioworks, Hyasynth Bio, InMed Pharmaceuticals, Librede, Renew Biopharma, Cronos Group, Organigram and Teewinot Life Sciences, etc. Anandia Laboratories, Gingko Bioworks, Hyasynth Bio are top 3 players and held % share in total in 2023.
Biosynthesis of Cannabinoids can be divided into THC, CBD and Others,, etc. THC is the mainstream product in the market, accounting for % share globally in 2023.
Biosynthesis of Cannabinoids is widely used in various fields, such as Food Industry, Medical Industry and Others,, etc. Food Industry provides greatest supports to the Biosynthesis of Cannabinoids industry development. In 2023, global % share of Biosynthesis of Cannabinoids went into Food Industry filed.
Report Scope
This report, based on historical analysis (2018-2023) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Biosynthesis of Cannabinoids market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
Anandia Laboratories
Gingko Bioworks
Hyasynth Bio
InMed Pharmaceuticals
Librede
Renew Biopharma
Cronos Group
Organigram
Teewinot Life Sciences
ICC International Cannabis Corp.
Biotii Technologies Corp.
Bristol-Myers Squibb
Biogen Inc.
GW Pharmaceuticals
Segment by Type
THC
CBD
Others
Food Industry
Medical Industry
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Biosynthesis of Cannabinoids market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2033).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Biosynthesis of Cannabinoids introduction, etc. Biosynthesis of Cannabinoids Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12MRA Research’s Conclusions of Biosynthesis of Cannabinoids market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by MRA Research.
Biosynthesis of Cannabinoids report published by MRA Research reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2023. Global Biosynthesis of Cannabinoids market is projected to reach US$ million in 2033, increasing from US$ million in 2023, with the CAGR of % during the period of 2023 to 2033. Demand from Food Industry and Medical Industry are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Biosynthesis of Cannabinoids industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033.
Globally, Biosynthesis of Cannabinoids key companies include Anandia Laboratories, Gingko Bioworks, Hyasynth Bio, InMed Pharmaceuticals, Librede, Renew Biopharma, Cronos Group, Organigram and Teewinot Life Sciences, etc. Anandia Laboratories, Gingko Bioworks, Hyasynth Bio are top 3 players and held % share in total in 2023.
Biosynthesis of Cannabinoids can be divided into THC, CBD and Others,, etc. THC is the mainstream product in the market, accounting for % share globally in 2023.
Biosynthesis of Cannabinoids is widely used in various fields, such as Food Industry, Medical Industry and Others,, etc. Food Industry provides greatest supports to the Biosynthesis of Cannabinoids industry development. In 2023, global % share of Biosynthesis of Cannabinoids went into Food Industry filed.
Report Scope
This report, based on historical analysis (2018-2023) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Biosynthesis of Cannabinoids market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
By Company
Anandia Laboratories
Gingko Bioworks
Hyasynth Bio
InMed Pharmaceuticals
Librede
Renew Biopharma
Cronos Group
Organigram
Teewinot Life Sciences
ICC International Cannabis Corp.
Biotii Technologies Corp.
Bristol-Myers Squibb
Biogen Inc.
GW Pharmaceuticals
Segment by Type
THC
CBD
Others
Segment by Application
Food Industry
Medical Industry
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Biosynthesis of Cannabinoids market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2033).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Biosynthesis of Cannabinoids introduction, etc. Biosynthesis of Cannabinoids Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12MRA Research’s Conclusions of Biosynthesis of Cannabinoids market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by MRA Research.